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Background: Previous studies suggest that the antioxidants vitamins C and E may protect against
development of knee osteoarthritis (OA). We examined the association of circulating levels of vitamin C
and E with incident whole knee radiographic OA (WKROA).
Methods: We performed a nested caseecontrol study of incident WKROA in MOST, a cohort of 3,026 men
and women aged 50e79 years with, or at high risk of, knee OA. Incident cases were knees without either
tibiofemoral (TF) or patellofemoral (PF) OA at baseline that developed TF and/or PF OA by 30-month
follow-up. Two control knees per case were selected from those eligible for WKROA that did not develop
it. Vitamin C and E (alpha-tocopherol) assays were done on baseline supernatant plasma (PCA) and
serum samples, respectively. We examined the association of gender-speciﬁc tertiles of vitamin C and E
with incident WKROA using logistic regression with GEE, adjusting for age, gender, and obesity.
Results: Subjects without WKROA at baseline who were in the highest tertile of vitamin C had a higher
incidence of WKROA [adjusted OR ¼ 2.20 (95% CI: 1.12e4.33); P-value ¼ 0.021], with similar results for
the highest tertile of vitamin E [adjusted OR ¼ 1.89 (1.02e3.50); P-value ¼ 0.042], compared to those in
the lowest tertiles. P-values for the trend of vitamin C and E tertiles and incident WKROA were 0.019 and
0.030, respectively.
Conclusions: Higher levels of circulating vitamin C and E did not provide protection against incident
radiographic knee OA, and may be associated with an increased risk of knee OA.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Background
Antioxidants have been investigated for their protective effect in
several chronic diseases. Vitamin C is a water-soluble vitamin with
antioxidant properties. Its role as an antioxidant has been investi-
gated in associationwith cardiovascular disease1, lipid proﬁles1 and
cancer prevention2. The antioxidant vitamin E (present in the forms
alpha-, beta-, delta-, and gamma-tocopherol), has also been studied: M.C. Nevitt, Department of
a, San Francisco, 185 Berry St,
1-415-514-8048; Fax: 1-415-
t).
s Research Society International. Pin the prevention of cardiovascular diseases3, and cancer4 and for
its effects on bone turnover markers in osteoporosis5.
Both vitamin C and E have also been considered for a potential
role in protecting joints from the development and progression of
osteoarthritis (OA). A cross-sectional study in patients with knee
OA found that those with severe OA had a decreased quantity of
reactive oxygen species scavengers in their joint ﬂuid compared to
patients with no knee OA6, suggesting a possible role for reactive
oxygen species in the development of OA and for antioxidants in
preventing it. Vitamin C is also an essential nutrient for the
biosynthesis of collagen matrix components7. In studies of animal
cartilage explants, vitamin C has been shown to be chon-
droprotective; supplementation of goat articular chondrocytes
with vitamin C reduced morphological degeneration of theseublished by Elsevier Ltd. All rights reserved.
Fig. 1. Subject selection ﬂow diagram.
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stimulate collagen synthesis in a study of guinea pig cartilage8.
However, not all animal studies suggest a protective effect of
vitamin C in OA. A recent study in Hartley guinea pigs found that
exposure to increased levels of vitamin C worsened the severity of
incident OA9.
In epidemiological studies, a higher dietary intake of vitamin C,
but not vitamin E, was associated with reduced structural pro-
gression of knee OA10, while dietary intake of these micronutrients
was not associated with the incidence of radiographic knee OA. A
study of healthy adults found that subchondral bone marrow le-
sions in the knee measured by MRI, which may be involved in the
pathogenesis of OA, were less common in those with higher dietary
intake of vitamin C11, but there was no association with cartilage
defects or cartilage volume nor of dietary intake of vitamin E with
any MRI measure. These studies estimated dietary consumption of
antioxidants from food frequency questionnaires (FFQ), a method
prone to misclassiﬁcation of micronutrient intake12. Dietary
vitamin C intake data show great variability and plasma levels may
better reﬂect long termvitamin C status12. For Vitamin E, the alpha-
tocopherol isoform has been shown to be reasonably estimated by
the FFQ method13,14. Two population studies have examined the
cross-sectional association of serum tocopherol (Vitamin E) levels
with prevalent knee OA, with inconsistent results that varied by
tocopherol isoform15,16 and gender15. Finally, a randomized trial in
individuals with clinical knee OA found no effect of daily vitamin E
supplementation (500 mg) on cartilage loss assessed by MRI or on
symptoms over 2 years17.
In this study we examined the association of baseline plasma
levels of vitamin C and serum levels of vitamin E with incident
whole knee radiographic OA (WKROA) during 30 months of follow-
up using data from the Multicenter OA (MOST) Study.
Methods
Study subjects
We performed a nested caseecontrol study of incident knee OA
among subjects in MOST, a prospective cohort study of 3,026 per-
sons aged 50e79 years of age who have knee OA or are at high-risk
for knee OA. Individuals at high-risk include were overweight, had
knee pain, aching or stiffness on most of the last 30 days, or had a
history of knee surgery or knee injury that made it difﬁcult to walk
for at least 1 week18. Subjects were recruited from two U.S. com-
munities, Birmingham, Alabama and Iowa City, Iowa through mass
mailings of letters and study brochures, supplemented by media
and community outreach campaigns; study protocols were
approved by Institutional Review Boards at all participating in-
stitutions. Persons who screened positive for rheumatoid arthritis,
ankylosing spondylitis, psoriatic arthritis, reactive arthritis19, renal
insufﬁciency requiring dialysis, a history of cancer, bilateral knee
replacement surgery, inability to walk without assistance, or plans
to leave the study area were excluded18.
Radiographic methods
Weight-bearing PA ﬁxed ﬂexion and lateral view knee radio-
graphs were obtained at the baseline and 30-month visit using a
plexiglass positioning frame (SynaFlexer TM)20. A musculoskeletal
radiologist and a rheumatologist experienced in evaluating knee
radiographs scored paired radiographs for KellgreneLawrence (Ke
L) grade and medial and lateral tibiofemoral (TF) and patellofe-
moral (PF) JSN (0e3)21. If readers disagreed on the presence or
incidence of TF or PF OA in a knee at any time-point, or worsening
of JSN (TF or PF) between time-points, ﬁnal determinations weremade by an adjudication panel of three readers22. Weighted kappas
for agreement between the two readers were as follows: KeL
grade ¼ 0.79; medial TF compartment JSN ¼ 0.81; lateral TF
compartment JSN ¼ 0.86; PF JSN ¼ 0.75. The kappa for PF OA (yes/
no) was 0.80 and for TF OA (yes/no) was 0.83.
Deﬁnition of WKROA
Whole knee ROA was considered present when a knee had
either TF OA, deﬁned as a KeL grade 2, and/or the presence of PF
OA, deﬁned as (1) a PF osteophyte grade 2 or (2) as a PF osteo-
phyte grade 1 plus one or more of PF JSN 2 or sclerosis 2 or
cysts 223. Incident WKROA was deﬁned as a knee that developed
WKROA at the 30-month follow-up that did not have it at baseline.
Incident TFROA and incident PFROAwere deﬁned as knees without
prevalent TF or PFROA, respectively, at baseline that developed it at
follow-up.
Selection of subjects for vitamin C and E assays
To be eligible for the nested caseecontrol study of vitamin C and
E and other nutritional assays subjects had to have 30 month
follow-up radiographic outcome data, one or two knees eligible for
incident WKROA and a readable baseline MRI and (n ¼ 1,581)
(Fig. 1). Although not the focus of this report, baseline MRIs were
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dictors of incident WKROA. From among subjects eligible for inci-
dentWKROA in one or both knees, we included as cases all subjects
who developed incident WKROA in at least one knee (n ¼ 150) and
randomly selected approximately two control subjects per case
(n ¼ 298), frequency matched by clinic site, from subjects eligible
for incident WKROA who did not develop it. Valid vitamin C and E
assay results were available for 145 (97%) incident cases and 282
(95%) controls.
Vitamin C and E assay methods
Blood samples for vitamin C and E assays were collected at the
baseline visit after an overnight fast. Both a plasma/PCA sample for
vitamin C, using light-protected processing tubes, and a serum
sample for vitamin E were processed immediately and stored at
70 before being shipped to Tufts-USDA Human Nutrition
Research Center on Aging (Boston, MA) where the samples were
again stored at 70. Sample concentrations of vitamin C and E
(alpha-tocopherol only) were then measured using HPLC assays
(Waters Associates, Inc.)24,25. Assays were run with subjects
grouped in several separate batches, each sent to the laboratory at
different times. The ratio of incident knee OA cases and controls in
each batch was 1e2.
The intraassay CV for vitamin C was 6.0%, and the interassay CV
was 4.5% .The normal range for vitamin Cwas considered to be 0.4e
2.20 mg/dL, similar to normal ranges reported in other published
studies26. The intraassay CV for assays for serum vitamin E was
5.6%, and the interassay CV was 3.5%. The normal range for vitamin
E was considered to be 500e1,800 ug/dL, also similar to published
ranges27. There were no signiﬁcant differences in mean vitamin C
(P-value ¼ 0.40) or E (P-value ¼ 0.58) levels between different
batches sent at different times. The median batch values for the
four batches of Vitamin C (1.326, 1.308, 1.310,1.269) and vitamin E
(1,521.5, 1,490.3, 1,681.7, 1,469.5) were all similar. All assays were
run in duplicate.
Other baseline measures
Prescribed and over-the-counter medication and micronutrient
supplement usewithin the previous 30days of the baseline visitwas
collected by self-report and inventory of participant-supplied
medication bottles. Current use and dose of supplements for
vitamin C and vitamin E were also assessed by direct question. The
modiﬁed self-report Charlson comorbidity questionnaire was
collected at baseline and the Charlson comorbidity index was
calculated28. Standing height (measured by Harpenden Stadi-
ometer) andweightweremeasured at baseline andused to calculate
the BMI29. Serum levels of 25-hydroxy vitamin D were measured
using commercially available radioimmunoassay kits (DiaSorin,
Stillwater, Minn), serum vitamin A using HPLC assays (Waters As-
sociates, Inc.) and plasma vitamin K using HPLC assays (40).
Statistical analysis
Ranges and sex-speciﬁc tertile cut-points for baseline vitamin C
and E levels were determined for men and women separately as
previous studies indicate that these levels may vary by sex14,30.
We performed knee-level analyses of incident WKROA using all
knees eligible for incident WKROA in both cases and controls.
Among the subjects with vitamin C and E data, there were 153
incident WKROA knees in 145 subjects and 561 knees without
WKROA at both baseline and follow-up in all 427 subjects. We
performed analyses separately in subjects who had both kneeseligible for incident WKROA (n ¼ 287) and in those who already
had unilateral WKROA at baseline (n ¼ 140).
Logistic regression with GEE to adjust for a subject’s potential
inter-knee correlation (Statistical Analysis System PROC GENMOD,
Version 9.2) was used to determine the association of sex-speciﬁc
tertiles of vitamin C and E with incident OA, adjusting for sex,
age, BMI, nonwhite race, and clinic site and in a separate analysis
mutually adjusting for vitamin C and E tertiles in a single model.
Tests for trend used the sex-speciﬁc median vitamin C and E values
for each tertile. We tested for gender by vitamin C and E level in-
teractions and performed stratiﬁed analyses when there were sig-
niﬁcant interactions.
We performed several sensitivity analyses. We evaluated the ef-
fects of adding additional individual covariates to the logisticmodels,
including use at baseline (yes/no) of vitamin C, vitamin E, vitamin D
andmultivitamin supplements, the dose of vitamin C, dietary intake
of vitaminE supplements, glucosamine/chondroitin supplement use,
the season in which blood samples were obtained, vitamin C and E
batch number, the subject’s fasting status at the time of phlebotomy,
education level, Charlson co-morbidity score, smoking status and the
presenceof baseline frequent kneepain.We also analyzedour results
adjusting for circulating blood levels of vitamin A, vitamin K and
vitamin D. We conducted a separate analysis excluding all vitamin C
and E supplement users. Finally, we performed key analyses using
incident TF OA (KeL grade 2) as the outcome.
We evaluated the possible effects of selection bias in the sam-
ples of incident cases and controls from each clinical site that might
result from the requirement to have readable baseline MRIs. For
this we re-estimated the key results using a weighted logistic
regression implemented by invoking the “weight” option in PROC
GENMOD, with the weights based on the clinic-speciﬁc probabili-
ties of inclusion of incident WKROA cases and controls as a pro-
portion of the total number of cases and controls at the clinic.
Results were similar to the unweighted regression analysis and are
not reported here.
Results
Subject characteristics
Baseline characteristics of subjects with incident WKROA and
controls were similar, except that the incident cases had a higher
average BMI and a greater percentage took glucosamine supple-
ments, were more likely to have unilateral WKROA at baseline and
to have frequent knee pain in one or both knees (Table I). Among
knees that developed incident WKROA, 82% of these knees devel-
oped incident TFROA only, and 14% developed incident PFROA only,
and 4% developed ROA in both joints.
Vitamin C and E ranges and sex-speciﬁc tertiles
There were signiﬁcant age-adjusted differences (P value
<0.0001) in vitamin C levels betweenwomen [mean value 1.43mg/
dL (SD ¼ 0.55)] and men [mean value 1.18 mg/dL (SD ¼ 0.56)] as
well as for vitamin E [women: mean value 1828 ug/dL (SD ¼ 789)];
men 1,562 ug/dL (SD ¼ 738). Sex-speciﬁc ranges for the tertiles of
the baseline vitamin C and E are shown in Table II. Vitamin C and
vitamin E levels weremoderately correlated in bothmen (Pearson’s
r ¼ 0.25) and women (Pearson’s r ¼ 0.29).
Vitamin C and E and incident WKROA
Among subjects with no WKROA in either knee (n ¼ 287 sub-
jects, 574 knees) at baseline, there was a trend (P ¼ 0.075) for an
association between sex-speciﬁc tertiles of vitamin C and incident
Table I
Baseline characteristics of participants by incident whole knee ROA status at follow-
up
Incident whole knee ROA sample
Subjects with
incident case
knees (n ¼ 145)
Subjects without
incident case
knees (n ¼ 282)
Age, mean (SD) 61.7 (7.7) 61.5 (7.7)
Sex (%Female) 88 (61%) 166 (59%)
BMI, mean (SD) 30.9 (5.3) 28.7 (4.4)*
Caucasian (%) 117 (81%) 244 (87%)
Clinic (% UIowa) 59 (41%) 121 (43%)
Vitamin C level (mg/dL) (SD) 1.37 (0.62) 1.31 (0.54)
Vitamin E level (ug/dL) (SD) 1,671.9 (762.6) 1,691.7 (735.0)
Chondroitin Use (%) 28 (19%) 41 (15%)
Glucosamine Use (%) 42 (29%) 54 (19%)*
Vitamin C supplementation (%) 31 (21%) 67 (24%)
Vitamin E supplementation (%) 49 (34%) 87 (31%)
Multivitamin supplementation (%) 78 (54%) 153 (54%)
Any vitamin supplements reported (%) 104 (72%) 205 (73%)
PASE activity score (SD) 182.9 (88.2) 185.6 (94.9)
Baseline Charlson co-morbidity score 0.36 (0.78) 0.55 (1.07)
Any comorbidity (%) 34 (23%) 84 (30%)
Subjects with unilateral knee
ROA at baseline (%)
73 (50%) 67 (23%)*
Subjects with frequent knee
pain in either or both knees
72 (50%) 96 (34%)*
Subjects with knee ROA or
frequent knee pain in either
or both knees (%)
100 (69%) 138 (49%)*
*P-value <0.05.
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site (Table II). With additional adjustment for BMI there was a
signiﬁcant test for trend across vitamin C tertiles for the association
with incident WKROA, with the estimated odds ratios consistent
with a dose-response relationship. The highest tertile of vitamin C
had twice the odds of incident WKROA compared to the lowest.
This association was attenuated but still signiﬁcant whenTable II
Association of baseline plasma vitamin C and E level and incident whole knee ROA in su
Incident ROA in subjects with no ROA in either knee a
Baseline vitamin C level Incident knee events/
Observations (%)
Model 1: adjusted OR (95
P-value
Lowest tertile
Women: 0.12e1.21
Men: 0.096e0.89
18/166 (10.8%) Reference 1.0
Middle tertile
Women: 1.22e1.58
Men: 0.90e1.33
27/202 (13.4%) 1.33 (0.68e2.62) 0.403
Highest tertile
Women: 1.584e3.69
Men: 1.34e2.66
35/206 (17.0%) 1.76 (0.93e3.32) 0.083
Test for trend 0.075
Baseline vitamin E level Incident knee events/
Observations (%)
Model 1: adjusted OR (95
P-value
Lowest tertile
Women: 582e1,390
Men: 333e1,172
23/198 (11.6%) Reference 1.0
Middle tertile
Women: 1,391e1940
Men: 1,173e1,660
21/164 (12.8%) 1.16 (0.59e2.25) 0.668
Highest tertile
Women: 1941e9,222
Men: 1,661e5,156
36/212 (17.0%) 1.70 (0.92e3.14) 0.088
Test for trend 0.061
Model 1 e Adjusted for age, sex, nonwhite race, clinic site.
Model 2 e Adjusted for age, sex, nonwhite race, clinic site and BMI.
Model 3 e Adjusted for age, sex, nonwhite race, clinic site, BMI and vitamin E/C tertiles.additionally adjusted for vitamin E (Table II). The interaction terms
for vitamin C tertiles and gender were not signiﬁcant (P ¼ 0.579).
Subjects without baseline WKROA in the highest tertile of
plasma vitamin E also had a signiﬁcant (P-value ¼ 0.042) twice the
odds increased risk of incident WKROA after adjusting for age, race,
gender, clinic site and BMI, which was attenuated with additional
adjustment for plasma vitamin C levels (Table II). An interaction
term for vitamin E and genderwas signiﬁcant (P¼ 0.039). In further
analyses stratifying for gender (Table III), women in the highest
tertile of vitamin E had an increased risk of incident WKROA
[OR¼ 3.43 (1.36e8.66); P-value¼ 0.009; P-value for trend¼ 0.014],
but there was no association in men [OR ¼ 0.99 (0.41e2.41); P-
value ¼ 0.989; P-value for trend ¼ 0.786]. Results were unchanged
when mutually adjusting for vitamin C and E levels.
Results for vitamin C levels were similar, although nonsigniﬁ-
cant, in the much smaller group of subjects (n ¼ 140 subjects, 140
knees) who had unilateral WKROA at baseline (data not shown).
The risk of incident WKROA in the contralateral knee was increased
for the highest tertile of vitamin C [adjusted OR ¼ 1.97 (95% CI:
0.83e4.70); P ¼ 0.125; P for trend ¼ 0.231]. For the subjects in the
highest tertile of vitamin E, however, the risk of developing
contralateral WKROA was nonsigniﬁcantly decreased compared to
the lowest tertile [adjusted OR ¼ 0.57 (0.24e1.39); P ¼ 0.218; (P for
trend: 0.174)]. Including levels of both antioxidants in the same
model did not substantially change these results.Additional analyses
Individual adjustment for the additional covariates described in
the Methods, including glucosamine/chondroitin and vitamin
supplement use, and circulating levels of vitamins A, D and K did
notmaterially change any of the results. Subjects using vitamin C or
E supplements had signiﬁcantly higher blood levels of vitamin C or
E; excluding them did not change any of the results. Our results
were largely unchanged when incident TFROA alone was analyzedbjects with no ROA in either knee at baseline
t baseline (n ¼ 574 knees, 287 subjects/80 events)
%CI); Model 2: adjusted OR (95%CI);
P-value
Model 3: adjusted OR (95%CI);
P-value
Reference 1.0 Reference 1.0
1.53 (0.76e3.10) 0.232 1.43 (0.71e2.89) 0.323
2.20 (1.12e4.33) 0.021 1.97 (1.00e3.88) 0.048
0.019 0.041
%CI); Model 2: adjusted OR (95%CI);
P-value
Model 3: adjusted OR (95%CI);
P-value
Reference 1.0 Reference 1.0
1.33 (0.68e2.63) 0.406 1.30 (0.66e2.56) 0.455
1.89 (1.02e3.50) 0.042 1.66 (0.91e3.04) 0.101
0.030 0.081
Table III
Association of baseline plasma vitamin E level and incident whole knee radiographic OA (WKROA) in subjects with no ROA at baseline: A. Women and B. Men
A. Incident WKROA-women only (n ¼ 336 knees, 168 ppts/50 events) B. Incident WKROA-men only (n ¼ 238 knees, 119 ppts/30 events)
Baseline vitamin
E level
Incident knee events/
Observations (%)
Model 2: adjusted OR
(95%CI); P-value
Model 3: adjusted OR
(95%CI); P-value
Incident knee events/
Observations (%)
Model 2: adjusted OR
(95%CI); P-value
Model 3: adjusted OR
(95%CI); P-value
The lowest tertile 10/112 (8.9%) Reference 1.0 Reference 1.0 13/86 (15.1%) Reference 1.0 Reference 1.0
Middle tertile 16/96 (16.7%) 2.86 (1.09e7.52) 0.033 2.72 (1.04e7.09) 0.041 5/68 (7.4%) 0.48 (0.17e1.34) 0.160 0.49 (0.17e1.39) 0.177
The highest tertile 24/128 (18.8%) 3.43 (1.36e8.66) 0.009 3.07 (1.24e7.60) 0.016 12/84 (14.3%) 0.99 (0.41e2.41) 0.990 0.85 (0.35e2.10) 0.729
Test for trend 0.014 0.026 0.786 0.934
Model 2 e Adjusted for age, nonwhite race, clinic site, and BMI.
Model 3 e Adjusted for age, nonwhite race, clinic site, BMI and vitamin E tertiles and vitamin C tertiles.
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incident PF OA for valid analysis.
Discussion
We evaluated the relationship of blood levels of the antioxidant
vitamins C and E with the risk of developing incident radiographic
knee OA and found higher plasma levels of vitamin C and E (spe-
ciﬁcally alpha-tocopherol) did not protect against incident radio-
graphic whole knee OA. Rather, subjects with vitamin C levels and
vitamin E levels in the highest tertile had signiﬁcantly increased
odds of developing WKROA. In addition, there was a signiﬁcant
dose-response trend for increasing levels of vitamin C and E and
odds of developing incident WKROA.
Our ﬁnding that higher plasma vitamin C levels increased inci-
dent WKROA is consistent with a recent animal study showing that
exposure to increased levels of vitamin C supplements worsened
the severity of incident OA9. Kraus et al. evaluated the dose
response of ascorbic acid with incident OA lesions in Hartley guinea
pigs. Guinea pigs fed a high concentration of ascorbic acid (150 mg/
day) over 8 months had a greater degree of proteoglycan loss,
cartilage ﬁbrillation and osteophyte formation than the group fed
low levels of ascorbic acid (2.5e3 mg/day). The investigators
postulated that the degenerative joint changes observed in the
guinea pig model may be mediated in part through the local pro-
duction of TGF-beta, which was found to be actively expressed in
the osteophytes of guinea pigs given higher doses of vitamin C.
Our results differ from our expectation that antioxidants may
protect against the development of knee OA and from some pre-
vious studies. In the longitudinal FraminghamOA study, McAlindon
and colleagues31 found that higher self-reported dietary intake of
vitamin C was associated with reduced joint space narrowing
progression in knees with existing TFROA, but dietary vitamin E
intake was not related to progression and neither micronutrient
was associated with incident TFROA. Wang et al.11 assessed dietary
intake of vitamin C and E in healthy middle-aged subjects without
knee pain and found that 10 years later the prevalence of TF bone
marrow lesions assessed by MRI was lower in those with a greater
vitamin C intake, but there was no association with the later
prevalence of cartilage defects. Vitamin E intake was not associated
with either MRI ﬁnding. Both studies used food FFQ to assess di-
etary vitamin C and E intake, amethod limited byweak correlations
with objective micronutrient biomarkers and misclassiﬁcation of
nutrient intake for vitamin C especially32,33. A more recent study
suggested that users of vitamin C supplements34 had a modest
decreased risk of incident TFROA. However, this study did not
distinguish past supplement intake from use at the study baseline,
and excluded over half of all enrolled subjects because they had
used multivitamins of any kind in the past.
Two previous cross-sectional population studies have examined
the association of blood levels of vitamin E with radiographic knee
OA, with results for alpha-tocopherol that are consistent with oursin not ﬁnding a protective effect of higher levels. In the Johnson
County OA study, Jordan et al.15 measured serum levels of tocoph-
erols in subjects with and without radiographic TF knee OA, and
found that a higher ratio of alpha to gamma tocopherol level was
associated with a signiﬁcantly decreased prevalence of OA, while
higher levels of delta-tocopherol and gamma-tocopherol were
associated with a signiﬁcant increase in the prevalence of OA. There
was no signiﬁcant association seen between levels of alpha
tocopherol and radiographic OA (ROA). A cross-sectional study
done in Japan found no association of alpha-tocopherol levels with
prevalent TF OA, but subjects in the highest tertile of undifferen-
tiated beta/gamma tocopherol had a signiﬁcantly reduced preva-
lence of OA16. Finally, in the only randomized, placebo controlled
trial of antioxidant supplementation and knee OA progression,
subjects receiving 500 mg vitamin E supplementation (which
contains mainly alpha-tocopherol) daily for 2 years showed no
difference compared to placebo in cartilage changes assessed over
the 2-year period by MRI17.
Several strengths and limitations of our study deserve
comment. Ours is the ﬁrst study to our knowledge to evaluate the
risk of incident radiographic knee OA with blood levels of both
vitamin C and E, which better reﬂect long-term circulating levels of
vitamin C than assessments of dietary intake using food FFQ32. In
addition, the MOST longitudinal cohort study had a high rate of
follow-up (89%) for radiographic outcomes.
We examined antioxidant levels and the risk of new radio-
graphic knee OA, a design valuable for establishing that the anti-
oxidant exposure occurred prior to the radiographic endpoint. We
do not present results for baseline antioxidant levels and radio-
graphic progression of existing knee OA because restricting our
analysis to knees with existing OA can generate substantial bias
(attenuating and even reversing true causal relationships) in the
apparent association of disease worsening with a chronic risk fac-
tor, such as blood antioxidant levels, when that risk factor is also
associated with disease onset35,36. Thus, associations of blood
antioxidant levels with disease progression would be largely
uninterpretable.
Our study also has several potential limitations. Incident OA
outcomes are based on radiographs, which are relatively insensitive
to very early knee OA37. However, this would tend to bias any as-
sociations of vitamin C and E levels toward null ﬁndings. Analyses
of vitamin C and E levels and kneeMRI ﬁndings arewarranted. Even
in a prospective study of incident OA such as ours, it is possible that
subjects with early signs or symptoms of knee OA may have been
more likely to take vitamin C and E and other nutritional supple-
ments in order to prevent disease onset, resulting in confounding
by indication. To try to control for this possibility, we did sensitivity
analyses excluding vitamin C and E supplement users, and adjust-
ing for glucosamine/chondroitin and other supplement use, and
this did not change our results. We studied ROA of the whole knee,
which is appropriate since circulating levels of vitamin C and E are
likely to affect both TF and PF compartments of the knee. However,
R.K. Chaganti et al. / Osteoarthritis and Cartilage 22 (2014) 190e196 195although we were able to analyze incident TF OA separately and
found similar associations with vitamin C and E levels, there were
too few incident PFROA cases for separate analyses. Therefore, our
ﬁndings may reﬂect primarily associations with TFROA.
Vitamin C and E levels were measured from single plasma and
serum sample at baseline only and may not reﬂect long-term
exposure or diurnal variation, while blood levels may not corre-
late strongly with antioxidant levels in joint ﬂuid. We assessed only
alpha-tocopherol levels. Alpha-tocopherol is found in higher
plasma and tissue concentrations than other forms, is the main
form of vitamin E in supplements and is one of the most potent
antioxidant tocopherols27. Nevertheless, our results are not directly
comparable with studies that have analyzed other tocopherol iso-
forms and isoform ratios16,17. Gamma-tocopherol may have anti-
inﬂammatory in addition to antioxidant properties and is a major
source of vitamin E in the diet38. We did not adjust alpha-
tocopherol levels for blood cholesterol levels, which may be a
source of confounding for fat soluble vitamin E. Further investiga-
tion of the role of various isoforms of tocopherol in OA is warranted.
The association of vitamin C and E levels with incident WKROA
was only signiﬁcant in models adjusted for BMI, a potent risk factor
for incident knee OA. Obese individuals have lower circulating
levels of ascorbic acid and other micronutrients antioxidants38,39,
possibly due to low dietary intake or depletion of antioxidants from
scavenging of reactive oxygen species, which are increased in
obesity. In our study adjustment for BMI strengthened the associ-
ation of vitamin C and E with incident disease. Consistent with one
other study15, our results suggested possible gender differences in
the relationship of alpha-tocopherol and the risk of knee OA; men
in our study in the higher tertiles of vitamin E had a small and
nonsigniﬁcantly decreased risk and women had a large and sig-
niﬁcant increased risk of knee OA. These results should be treated
with caution given the relatively small number of events in themen
and wide conﬁdence intervals.
In conclusion, higher plasma level of the antioxidants vitamin C
and serum level of vitamin E at baseline were associated with an
increased risk of incident whole knee ROA and therefore we would
argue against the routine use of vitamin C or E supplementation to
prevent knee OA. A possible causal role of high vitamin C and E
levels in knee OA development and the full spectrum of antioxidant
effects in knee OA warrant further investigation.
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